Coherus BioSciences Inc (NASDAQ:CHRS)

7.64
Delayed Data
As of 4:00pm ET
 +0.23 / +3.10%
Today’s Change
7.24
Today|||52-Week Range
19.32
-52.13%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues30.0M190.1M1.6M0.00
 
 
 
 
Depreciation And Amortization1.9M3.0M3.4M3.2M
 
 
 
 
 
 
Operating ExpensesGross Income-------3.2M
 
 
General Expenses246.9M303.0M226.1M197.3M
 
 
 
 
 
Research And Development212.7M254.4M160.5M106.4M
 
 
 
 
 
Total Operating Expenses248.7M306.0M229.5M200.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-218.7M-115.9M-228.0M-200.6M
 
 
 
 
 
Extraordinary Credit0.000.002.3M3.2M
 
 
 
Extraordinary Charge-5.0M-4.3M-4.2M-3.9M
 
 
 
 
 
Interest Expense On Debt33.0K8.0M9.6M9.7M
 
 
 
 
 
Other Expenses-239.0K428.0K1.1M1.5M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-223.9M-127.8M-238.3M-209.4M
 
 
 
 
 
Minority Interest-678.0K-451.0K-116.0K-70.0K
 
 
 
 
 
Net Income-223.3M-127.3M-238.2M-209.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS37.1M41.9M53.1M65.0M
 
 
 
 
 
Shares To Calculate EPS Diluted37.1M41.9M53.1M65.0M
 
 
 
 
 
 
Earnings Per ShareEPS-$6.01-$3.04-$4.48-$3.22
 
 
 
 
 
EPS Diluted-$6.01-$3.04-$4.48-$3.22